Accelerating clinical trials with AI

FOUNDERS

Charles Fisher

Aaron Smith

Jonathan Walsh

INDUSTRY

Healthcare

MILESTONE

Radical Investment: 2022

San Francisco-based Unlearn has devised a powerful way to apply AI to improve clinical trials. Using advanced biostatistics and machine learning, Unlearn creates “digital twins” of clinical trial participants, reducing the number of actual humans that need to be recruited for control arms. This makes clinical trials cheaper and faster to execute, ultimately enabling life-changing therapeutics to reach patients sooner.

Founders

Tamer Mohamed
Sam Wadsworth
Simon Beyer

Founders

Kevin Terrell
Sumant Kawale
Yinhan Liu

Founders

Himanshu Gupta
Max Evans

Founders

Aidan Gomez
Nick Frosst
Ivan Zhang

Founders

Pieter Abbeel
Peter Chen
Rocky Duan
Tianhao Zhang

Founders

Alexandre Robicquet
Emile Contal
Sebastian Thrun

Founders

Evan Feinberg
Ben Sklaroff

Founder

George Sivulka

Founder

Kay Giesecke

Founder

Ann Garnier

Founders

Jonny Dyer
Dan McCleese
Pascal Stang
Paul Day
Reuben Rohrschneider

Founders

Awais Ahmed
Kshitij Khandelwel

Founders

Ramtin Attar
Reza Nasseri

Founders

Rishi Nayyar
Harsh Nayyar

Founder

Benjamin Schmidt

Founder

Corey Gross

Founders

Tomi Poutanen
Dr. Muhammad Mamdani
Mara Lederman

Founder

Ben Nashman

Founders

Jae Lee
Aiden Lee
SJ Kim
Soyoung Lee
David Chung

Founders

Charles Fisher
Aaron Smith
Jonathan Walsh

Founders

Martin Snelgrove
Darrick Wiebe

Founder

Raquel Urtasun

Founder

Christian Weedbrook

Founders

Richard Socher
Bryan McCann

© 2022 Radical Ventures Investments Inc.